Avricore Health (AVCRF) Interest & Investment Income (2009 - 2026)
Avricore Health (AVCRF) posted quarterly Interest & Investment Income of $453.27 for Q2 2026, down 83.79% year-over-year from $2796.6 in Q2 2025, and down 84.58% quarter-over-quarter from $2939.3 in Q4 2025.
Avricore Health (AVCRF) Interest & Investment Income (2009 - 2026) Analysis & Trends
Avricore Health (AVCRF) has reported Interest & Investment Income for 9 consecutive years, with $453.27 the latest figure, recorded in Q2 2026.
- In Q2 2026, Interest & Investment Income fell 83.79% year-over-year to $453.27; the TTM figure through Jun 2026 stood at $8622.0 (up 136.46% YoY), while the FY2025 annual figure was $8677.4, up 861.97% from the prior year.
- Interest & Investment Income retreated to $453.27 in Q2 2026 per AVCRF's latest filing, from $2939.3 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $2939.3 in Q4 2025 and bottomed at $6.68 in Q1 2024.
- Historically, Interest & Investment Income has averaged $1130.2 across 5 years, with a median of $608.54 in 2025.
- Annual changes were most pronounced in 2023 — Interest & Investment Income sank 99.72% — and 2025, when it surged 8268.4%.
- Avricore Health's Interest & Investment Income stood at $1684.8 in 2022, then tumbled by 60.94% to $658.14 in 2023, then plunged by 77.43% to $148.56 in 2024, then surged by 1878.61% to $2939.3 in 2025, then tumbled by 84.58% to $453.27 in 2026.
- Business Quant data shows AVCRF's Interest & Investment Income at $453.27 in Q2 2026, $2939.3 in Q4 2025, and $2432.8 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 207.00 Mn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 61.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | - |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 13.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 7.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 606,000.00 |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 8.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 5.60 Mn |
| 10 | Avricore Health | 3.04 Mn | 3.01 Mn | -6.20 Bn | 453.27 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 453.27 |
| Dec 31, 2025 | 8,693.95 |
| Sep 30, 2025 | 5,831.25 |
| Jun 30, 2025 | 3,375.45 |
| Mar 31, 2025 | 558.93 |
| Dec 31, 2024 | 884.07 |
| Sep 30, 2024 | 148.08 |
| Jun 30, 2024 | 141.11 |
| Mar 31, 2024 | 6.68 |
| Dec 31, 2023 | 2,412.21 |
| Sep 30, 2023 | 1,781.28 |
| Jun 30, 2023 | 1,771.05 |
| Mar 31, 2023 | 1,677.63 |
| Dec 31, 2022 | 5,956.98 |
| Sep 30, 2022 | 4,446.36 |
| Jun 30, 2022 | 2,096.54 |
| Mar 31, 2022 | 135.00 |
| Dec 31, 2021 | 460.93 |
| Sep 30, 2021 | 74.67 |
| Jun 30, 2021 | 76.47 |